RENAL TUBERCULOSIS – A CHALLENGE IN DIAGNOSTIC AND TREATEMENT
Accepted
28 March 2026
Available Online
15 September 2018
Abstract
TUBERCULOSIS IS CAUSED BY A BACTERIA CALLED MYCOBACTERIUM TUBERCULOSIS. THESE DESEASE STILL REMAINS A SERIOS HEALT H ISSUE IN UNDEVELOPED COUNTRIES. IT USSUALY AFFECTS THE RESPIRATORY TRACT, BUT ALSO HAVE EXTRAPULMOARY LOCATIONS. FROM THE EXTRAPULMONARY CASES, RENAL TUBERCULOSIS IS FO UND IN 27% OF THE CASES. EXTRAPULMONARY TUBERCULOSIS IS USUALY DISCOVERED IN PATIENTS WITH DEPRESED IMMUNE SYSTEM LIKE PATIENTS WITH HIV AND AFTER DIFFERENT ORGAN TRANSPLANTATION. THE INVOLVEMENTT OF THE KIDNEY IN TUBERCULOSIS CAN BE PART OF A DISSEMINATED INFECTION OR A LOCALIZED GENITOURINARY DISEASE, AND IT REPRESENTS A CHALLENGE IN DIAG NOSTIC. THE PATIENTS WITH RENAL TUBERCULOSIS PRESENTS STERILE PYURIA. AS TREATEMENT, THE FIRST LINE IS REPRESENTED BY ISONIAZIDE, RIFAMPICIN, PIRAZINAMIDE, ETHAMBUTOL, AND STREPTOMYCIN, BUT NOT IN FEW CASES SURGICAL INTERVENTION IS REQUIRED BECAUSE IF LEFT UNTREATED CAN LEAD TO RENAL DISTRUCTION, OR A SMALL AND UNEXTENDABLE BLADDER.
Keywords
TUBERCULOSIS
TREATMENT
SURGERY
KIDNEY
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
Zhukova II, Kulchavenia EV, Kholtobin DP, Brizhatiuk EV, Khomiako v VT, et al . Urogenital tuberculosis today. Urologia2013; 1: 13–6.
[2]
Diaconu CC, Stănescu AMA, Pantea Stoian A, Tincu RC, Cobilinschi C, Dragomirescu RIF, Socea B, Spînu DA, Marcu D, Socea LI, Bratu OG. Hyperkalemia and cardiovascular diseases: new molecules for the treatment. Rev Chim (Bucharest) 2018, 69(6):1367-1370
[3]
Manea M, Marcu D, Pantea Stoian A, Gaman MA, Gaman AM, Socea B, Neagu TP, Stanescu AM, Bratu O, Diaconu C. Heart failure with preserved ejection fraction and atrial fibrillation. A review, Revista de chimie, 2018, 69(11): 4180-4184
[4]
Diaconu CC, Manea M., Iancu MA, Stanescu AMA, Socea B, Spinu DA, Marcu D, Bratu OG . Hiponatremia in patients with heart failure: a prognostic marker. Revista de Chimie. 2018. 69; 5:1071-1074
[5]
Diaconu CC, Dragoi CM, Bra tu OG, Neagu TP, Pantea Stoian A, Cobelschi PC, Nicolae AC, Iancu MA, Hainarosie R, Stanescu AMA, Socea B . New approaches and perspectives for the pharmacological treatment of arterial hypertension. Farmacia 2018, 66(3):408-415
[6]
Niculae A, Peride I, Vinerea nu V, Rădulescu D, Bratu O, Geavlete B, Checheriță IA . Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS). Rom J Morphol Embriol 2017;58(3): 1065-1068.
[7]
Mititelu R, BratuO. Radionuclide Imaging. An Update on the Use of Dynamic Renal Scintigraphy.Modern Medicine, 2017, 24(4), p. 199-203
[8]
Constantinoiu S, Bârlă R, Iosif C, Cociu L, Gîndea C, Hoară P, Bratu O, Ruşitoru L . Difficulties in diagnosis and surgical treatment of a giant retroperitoneal lipoma. Chirurgia 2009;104(3): 363-367.
[9]
Diaconescu D, Stoian Pantea A, Socea L, Stanescu AM, Iancu M, Socea B, Pituru S, Bratu O, Diaconu C. Hepatorenal Syndrome: A Review. Archives of the Balkan Medical Union, 2018, 53(2), pag. 239-245
[10]
World Health Organization . Tuberculosis and HIV . Available at: http://www.who.int/hiv/topics/tb/en/. Accessed September 10, 2012.
[11]
Nourse PJ, Cotton MF, Bates WD. Renal manifestations in children co-infected with HIV and disseminated tuberculosis. Pediatr Nephrol, 2010, 25: 1759–1763
[12]
Matuck TA, Brasil P, Alvarenga MF, Morgado L, Rels MD, da Costa AC, Arau ́ jo M, Rodrigues ME, de Carvalho Dde B . Tuberculosis in renal transplants in Rio de Janeiro . Transplant Proc, 2004, 36: 905– 906.
[13]
Eastwood JB, Dilly SA, Grange JM . Tuberculosis, leprosy and other mycobacterial diseases. Cattell WR, ed. Infections of the Kidney and Urinary Tract. Oxford, UK: Oxford University Press, 1996, 291–318.
[14]
Eastwood JB, Corbishley CM, Grange JM . Tuberculosis and the kidney . J Am Soc Nephrol, 2001, 12: 1307–1314.
[15]
Yarger WE , 1991. Urinary tract obstructive . Brenner BM, Rector FC, eds. The Kidney. Fourth edition. Saunders: Philadelphia/ London: W.B. Saunders, 1768–1808.
[16]
Draghici T, Negreanu L, Bratu O, Tincu R, Socea B, Iancu M, Stanescu AM, Diaconu C . Liver abnormalities in patients with heart failure. Archives of the Balkan Medical Union, 2018, 53, (1), p. 76-81.
[17]
Paraschiv B, Dediu G, Iancu A, Bratu O, Diaconu C. Superior vena cava syndrome. Archives of the Balkan Medical Union, 2017, 52(1), p. 39-43
[18]
Min-Bo Yan, Jing Lu, Xiao -Feng Li, Zhen -Yu Guo . Clinical analysis of retroperitoneoscopic nephroureterectomy for renal tuberculosis. Chronic Diseases and Translational Medicine, 2015, 1, 217e220
[19]
Vinayak Gorakhanath Wagaskar, Rahul Arun Chirmade, Vidyasagar Hansraj Baheti, Harshawardhan Vedpalsingh Tanwa, Sujata Kiran Patwardhan, Ganesh Gopalakrishnan . Urinary Tuberculosis with Renal Failure: Challenges in Management DOI: 10.7860/JCDR/2016/16409.7017
[20]
Mochalova TP, Starikova IY. Reconstructive surgery for treatment of urogenital tuberculosis: 30 years of observation. World J Surg, 1997, 21: 511–515
[21]
S. Toccaceli, L. Perisco Stella, M. Diana, A. Taccone, G. Giulliani, L. de Paola, M. Valvano . Renal tuberculosis: a case report. G Chir, 2015, 36(2), p. 76
[22]
Miller WT. Tuberculosis in the 1990’s. Radiol Clin North Am. 1994;32:649e661.
[23]
Neibling HA, Walters W. Adenocarcinoma and tuberculosis of the same kidney: review of the literature and report of seven cases. J Urol. 1948;59:1022e1026.
[24]
Conde Redondo C, Estebanez Zarranz J, Rodriguez Toves A, et al. Tuberculosis and renal cancer. Actas Urol Esp. 1999;23:617e620.
[25]
Zhang X, Zheng T, Ma X, et al. Comparison of retroperitoneoscopic nephrectomy versus open approaches to non-functioning tuberculous kidneys: a report of 44 cases. J Urol. 2005;173: 1586e1589.
[26]
Chibber PJ, Shah HN, Jain P . Laparoscopic nephroureterectomy for tuberculous nonfunctioning kidneys compared with laparoscopic nephroureterectomy for other diseases. J Laparoendosc Adv Surg Tech A. 2005 Jun;15(3):308e311.